Skip to main content
Erschienen in: Cancer Causes & Control 5/2010

01.05.2010 | Original paper

Human papillomavirus is not associated with colorectal cancer in a large international study

verfasst von: Michele C. Gornick, Xavier Castellsague, Gloria Sanchez, Thomas J. Giordano, Michelle Vinco, Joel K. Greenson, Gabriel Capella, Leon Raskin, Gad Rennert, Stephen B. Gruber, Victor Moreno

Erschienen in: Cancer Causes & Control | Ausgabe 5/2010

Einloggen, um Zugang zu erhalten

Abstract

Objective of the study

Recent publications have reported an association between colon cancer and human papillomaviruses (HPV), suggesting that HPV infection of the colonic mucosa may contribute to the development of colorectal cancer.

Methods

The GP5+/GP6+ PCR reverse line blot method was used for detection of 37 types of human papillomavirus (HPV) in DNA from paraffin-embedded or frozen tissues from patients with colorectal cancer (n = 279) and normal adjacent tissue (n = 30) in three different study populations, including samples from the United States (n = 73), Israel (n = 106) and Spain (n = 100). Additionally, SPF10 PCR was run on all samples (n = 279) and the Innogenetics INNO-LiPA assay was performed on a subset of samples (n = 15).

Results

All samples were negative for all types of HPV using both the GP5+/GP6+ PCR reverse line blot method and the SPF10 INNO-LiPA method.

Conclusions

We conclude that HPV types associated with malignant transformation do not meaningfully contribute to adenocarcinoma of the colon.
Literatur
1.
Zurück zum Zitat Bosch FX, de Sanjose S (2002) Human papillomavirus in cervical cancer. Curr Oncol Rep 4(2):175–183CrossRefPubMed Bosch FX, de Sanjose S (2002) Human papillomavirus in cervical cancer. Curr Oncol Rep 4(2):175–183CrossRefPubMed
2.
Zurück zum Zitat Schiffman MH, Bauer HM, Hoover RN, Glass AG, Cadell DM, Rush BB et al (1993) Epidemiologic evidence showing that human papillomavirus infection causes most cervical intraepithelial neoplasia. J Natl Cancer Inst 85(12):958–964CrossRefPubMed Schiffman MH, Bauer HM, Hoover RN, Glass AG, Cadell DM, Rush BB et al (1993) Epidemiologic evidence showing that human papillomavirus infection causes most cervical intraepithelial neoplasia. J Natl Cancer Inst 85(12):958–964CrossRefPubMed
3.
Zurück zum Zitat zur Hausen H (1996) Papillomavirus infections—a major cause of human cancers. Biochim Biophys Acta 1288(2):F55–F78PubMed zur Hausen H (1996) Papillomavirus infections—a major cause of human cancers. Biochim Biophys Acta 1288(2):F55–F78PubMed
4.
Zurück zum Zitat Munoz N, Bosch FX, de Sanjose S, Herrero R, Castellsague X, Shah KV et al (2003) Epidemiologic classification of human papillomavirus types associated with cervical cancer. N Engl J Med 348(6):518–527CrossRefPubMed Munoz N, Bosch FX, de Sanjose S, Herrero R, Castellsague X, Shah KV et al (2003) Epidemiologic classification of human papillomavirus types associated with cervical cancer. N Engl J Med 348(6):518–527CrossRefPubMed
5.
Zurück zum Zitat Walboomers JM, Jacobs MV, Manos MM, Bosch FX, Kummer JA, Shah KV et al (1999) Human papillomavirus is a necessary cause of invasive cervical cancer worldwide. J Pathol 189(1):12–19CrossRefPubMed Walboomers JM, Jacobs MV, Manos MM, Bosch FX, Kummer JA, Shah KV et al (1999) Human papillomavirus is a necessary cause of invasive cervical cancer worldwide. J Pathol 189(1):12–19CrossRefPubMed
6.
Zurück zum Zitat Schlecht NF, Kulaga S, Robitaille J, Ferreira S, Santos M, Miyamura RA et al (2001) Persistent human papillomavirus infection as a predictor of cervical intraepithelial neoplasia. JAMA 286(24):3106–3114CrossRefPubMed Schlecht NF, Kulaga S, Robitaille J, Ferreira S, Santos M, Miyamura RA et al (2001) Persistent human papillomavirus infection as a predictor of cervical intraepithelial neoplasia. JAMA 286(24):3106–3114CrossRefPubMed
7.
Zurück zum Zitat Schiffman M, Castle PE, Jeronimo J, Rodriguez AC, Wacholder S (2007) Human papillomavirus and cervical cancer. Lancet 370(9590):890–907CrossRefPubMed Schiffman M, Castle PE, Jeronimo J, Rodriguez AC, Wacholder S (2007) Human papillomavirus and cervical cancer. Lancet 370(9590):890–907CrossRefPubMed
8.
Zurück zum Zitat Madeleine MM, Daling JR, Carter JJ, Wipf GC, Schwartz SM, McKnight B et al (1997) Cofactors with human papillomavirus in a population-based study of vulvar cancer. J Natl Cancer Inst 89(20):1516–1523CrossRefPubMed Madeleine MM, Daling JR, Carter JJ, Wipf GC, Schwartz SM, McKnight B et al (1997) Cofactors with human papillomavirus in a population-based study of vulvar cancer. J Natl Cancer Inst 89(20):1516–1523CrossRefPubMed
9.
Zurück zum Zitat Goffin F, Mayrand MH, Gauthier P, Alobaid A, Lussier C, Provencher D et al (2006) High-risk human papillomavirus infection of the genital tract of women with a previous history or current high-grade vulvar intraepithelial neoplasia. J Med Virol 78(6):814–819CrossRefPubMed Goffin F, Mayrand MH, Gauthier P, Alobaid A, Lussier C, Provencher D et al (2006) High-risk human papillomavirus infection of the genital tract of women with a previous history or current high-grade vulvar intraepithelial neoplasia. J Med Virol 78(6):814–819CrossRefPubMed
10.
Zurück zum Zitat Madsen BS, Jensen HL, van den Brule AJ, Wohlfahrt J, Frisch M (2008) Risk factors for invasive squamous cell carcinoma of the vulva and vagina—population-based case-control study in Denmark. Int J Cancer 122(12):2827–2834CrossRefPubMed Madsen BS, Jensen HL, van den Brule AJ, Wohlfahrt J, Frisch M (2008) Risk factors for invasive squamous cell carcinoma of the vulva and vagina—population-based case-control study in Denmark. Int J Cancer 122(12):2827–2834CrossRefPubMed
11.
Zurück zum Zitat Daling JR, Madeleine MM, Schwartz SM, Shera KA, Carter JJ, McKnight B et al (2002) A population-based study of squamous cell vaginal cancer: HPV and cofactors. Gynecol Oncol 84(2):263–270CrossRefPubMed Daling JR, Madeleine MM, Schwartz SM, Shera KA, Carter JJ, McKnight B et al (2002) A population-based study of squamous cell vaginal cancer: HPV and cofactors. Gynecol Oncol 84(2):263–270CrossRefPubMed
12.
Zurück zum Zitat Daling JR, Sherman KJ (1992) Relationship between human papillomavirus infection and tumours of anogenital sites other than the cervix. IARC Sci Publ 119:223–241PubMed Daling JR, Sherman KJ (1992) Relationship between human papillomavirus infection and tumours of anogenital sites other than the cervix. IARC Sci Publ 119:223–241PubMed
13.
Zurück zum Zitat Frisch M, Glimelius B, van den Brule AJ, Wohlfahrt J, Meijer CJ, Walboomers JM et al (1997) Sexually transmitted infection as a cause of anal cancer. N Engl J Med 337(19):1350–1358CrossRefPubMed Frisch M, Glimelius B, van den Brule AJ, Wohlfahrt J, Meijer CJ, Walboomers JM et al (1997) Sexually transmitted infection as a cause of anal cancer. N Engl J Med 337(19):1350–1358CrossRefPubMed
14.
Zurück zum Zitat Daling JR, Madeleine MM, Johnson LG, Schwartz SM, Shera KA, Wurscher MA et al (2004) Human papillomavirus, smoking, and sexual practices in the etiology of anal cancer. Cancer 101(2):270–280CrossRefPubMed Daling JR, Madeleine MM, Johnson LG, Schwartz SM, Shera KA, Wurscher MA et al (2004) Human papillomavirus, smoking, and sexual practices in the etiology of anal cancer. Cancer 101(2):270–280CrossRefPubMed
15.
Zurück zum Zitat Bjorge T, Engeland A, Luostarinen T, Mork J, Gislefoss RE, Jellum E et al (2002) Human papillomavirus infection as a risk factor for anal and perianal skin cancer in a prospective study. Br J Cancer 87(1):61–64CrossRefPubMed Bjorge T, Engeland A, Luostarinen T, Mork J, Gislefoss RE, Jellum E et al (2002) Human papillomavirus infection as a risk factor for anal and perianal skin cancer in a prospective study. Br J Cancer 87(1):61–64CrossRefPubMed
16.
Zurück zum Zitat Tornesello ML, Duraturo ML, Losito S, Botti G, Pilotti S, Stefanon B et al (2008) Human papillomavirus genotypes and HPV16 variants in penile carcinoma. Int J Cancer 122(1):132–137CrossRefPubMed Tornesello ML, Duraturo ML, Losito S, Botti G, Pilotti S, Stefanon B et al (2008) Human papillomavirus genotypes and HPV16 variants in penile carcinoma. Int J Cancer 122(1):132–137CrossRefPubMed
17.
Zurück zum Zitat Heideman DA, Waterboer T, Pawlita M, Delis-van Diemen P, Nindl I, Leijte JA et al (2007) Human papillomavirus-16 is the predominant type etiologically involved in penile squamous cell carcinoma. J Clin Oncol 25(29):4550–4556CrossRefPubMed Heideman DA, Waterboer T, Pawlita M, Delis-van Diemen P, Nindl I, Leijte JA et al (2007) Human papillomavirus-16 is the predominant type etiologically involved in penile squamous cell carcinoma. J Clin Oncol 25(29):4550–4556CrossRefPubMed
18.
Zurück zum Zitat Daling JR, Madeleine MM, Johnson LG, Schwartz SM, Shera KA, Wurscher MA et al (2005) Penile cancer: importance of circumcision, human papillomavirus and smoking in in situ and invasive disease. Int J Cancer 116(4):606–616CrossRefPubMed Daling JR, Madeleine MM, Johnson LG, Schwartz SM, Shera KA, Wurscher MA et al (2005) Penile cancer: importance of circumcision, human papillomavirus and smoking in in situ and invasive disease. Int J Cancer 116(4):606–616CrossRefPubMed
19.
Zurück zum Zitat Rubin MA, Kleter B, Zhou M, Ayala G, Cubilla AL, Quint WG et al (2001) Detection and typing of human papillomavirus DNA in penile carcinoma: evidence for multiple independent pathways of penile carcinogenesis. Am J Pathol 159(4):1211–1218PubMed Rubin MA, Kleter B, Zhou M, Ayala G, Cubilla AL, Quint WG et al (2001) Detection and typing of human papillomavirus DNA in penile carcinoma: evidence for multiple independent pathways of penile carcinogenesis. Am J Pathol 159(4):1211–1218PubMed
20.
Zurück zum Zitat Iwasawa A, Kumamoto Y, Fujinaga K (1993) Detection of human papillomavirus deoxyribonucleic acid in penile carcinoma by polymerase chain reaction and in situ hybridization. J Urol 149(1):59–63PubMed Iwasawa A, Kumamoto Y, Fujinaga K (1993) Detection of human papillomavirus deoxyribonucleic acid in penile carcinoma by polymerase chain reaction and in situ hybridization. J Urol 149(1):59–63PubMed
21.
Zurück zum Zitat Ritchie JM, Smith EM, Summersgill KF, Hoffman HT, Wang D, Klussmann JP et al (2003) Human papillomavirus infection as a prognostic factor in carcinomas of the oral cavity and oropharynx. Int J Cancer 104(3):336–344CrossRefPubMed Ritchie JM, Smith EM, Summersgill KF, Hoffman HT, Wang D, Klussmann JP et al (2003) Human papillomavirus infection as a prognostic factor in carcinomas of the oral cavity and oropharynx. Int J Cancer 104(3):336–344CrossRefPubMed
22.
Zurück zum Zitat Gillison ML, Koch WM, Capone RB, Spafford M, Westra WH, Wu L et al (2000) Evidence for a causal association between human papillomavirus and a subset of head and neck cancers. J Natl Cancer Inst 92(9):709–720CrossRefPubMed Gillison ML, Koch WM, Capone RB, Spafford M, Westra WH, Wu L et al (2000) Evidence for a causal association between human papillomavirus and a subset of head and neck cancers. J Natl Cancer Inst 92(9):709–720CrossRefPubMed
23.
Zurück zum Zitat Ringstrom E, Peters E, Hasegawa M, Posner M, Liu M, Kelsey KT (2002) Human papillomavirus type 16 and squamous cell carcinoma of the head and neck. Clin Cancer Res 8(10):3187–3192PubMed Ringstrom E, Peters E, Hasegawa M, Posner M, Liu M, Kelsey KT (2002) Human papillomavirus type 16 and squamous cell carcinoma of the head and neck. Clin Cancer Res 8(10):3187–3192PubMed
24.
Zurück zum Zitat Torrente MC, Ampuero S, Abud M, Ojeda JM (2005) Molecular detection and typing of human papillomavirus in laryngeal carcinoma specimens. Acta Otolaryngol 125(8):888–893PubMed Torrente MC, Ampuero S, Abud M, Ojeda JM (2005) Molecular detection and typing of human papillomavirus in laryngeal carcinoma specimens. Acta Otolaryngol 125(8):888–893PubMed
25.
Zurück zum Zitat Almadori G, Cadoni G, Cattani P, Posteraro P, Scarano E, Ottaviani F et al (1996) Detection of human papillomavirus DNA in laryngeal squamous cell carcinoma by polymerase chain reaction. Eur J Cancer 32A(5):783–788CrossRefPubMed Almadori G, Cadoni G, Cattani P, Posteraro P, Scarano E, Ottaviani F et al (1996) Detection of human papillomavirus DNA in laryngeal squamous cell carcinoma by polymerase chain reaction. Eur J Cancer 32A(5):783–788CrossRefPubMed
26.
Zurück zum Zitat Manjarrez ME, Ocadiz R, Valle L, Pacheco C, Marroquin A, De la Torre C et al (2006) Detection of human papillomavirus and relevant tumor suppressors and oncoproteins in laryngeal tumors. Clin Cancer Res 12(23):6946–6951CrossRefPubMed Manjarrez ME, Ocadiz R, Valle L, Pacheco C, Marroquin A, De la Torre C et al (2006) Detection of human papillomavirus and relevant tumor suppressors and oncoproteins in laryngeal tumors. Clin Cancer Res 12(23):6946–6951CrossRefPubMed
27.
Zurück zum Zitat Brandwein MS, Nuovo GJ, Biller H (1993) Analysis of prevalence of human papillomavirus in laryngeal carcinomas. Study of 40 cases using polymerase chain reaction and consensus primers. Ann Otol Rhinol Laryngol 102(4 Pt 1):309–313PubMed Brandwein MS, Nuovo GJ, Biller H (1993) Analysis of prevalence of human papillomavirus in laryngeal carcinomas. Study of 40 cases using polymerase chain reaction and consensus primers. Ann Otol Rhinol Laryngol 102(4 Pt 1):309–313PubMed
28.
Zurück zum Zitat Perez LO, Abba MC, Laguens RM, Golijow CD (2005) Analysis of adenocarcinoma of the colon and rectum: detection of human papillomavirus (HPV) DNA by polymerase chain reaction. Colorectal Dis 7(5):492–495CrossRefPubMed Perez LO, Abba MC, Laguens RM, Golijow CD (2005) Analysis of adenocarcinoma of the colon and rectum: detection of human papillomavirus (HPV) DNA by polymerase chain reaction. Colorectal Dis 7(5):492–495CrossRefPubMed
29.
Zurück zum Zitat Bodaghi S, Yamanegi K, Xiao SY, Da Costa M, Palefsky JM, Zheng ZM (2005) Colorectal papillomavirus infection in patients with colorectal cancer. Clin Cancer Res 11(8):2862–2867CrossRefPubMed Bodaghi S, Yamanegi K, Xiao SY, Da Costa M, Palefsky JM, Zheng ZM (2005) Colorectal papillomavirus infection in patients with colorectal cancer. Clin Cancer Res 11(8):2862–2867CrossRefPubMed
30.
Zurück zum Zitat Buyru N, Tezol A, Dalay N (2006) Coexistence of K-ras mutations and HPV infection in colon cancer. BMC Cancer 6:115CrossRefPubMed Buyru N, Tezol A, Dalay N (2006) Coexistence of K-ras mutations and HPV infection in colon cancer. BMC Cancer 6:115CrossRefPubMed
31.
Zurück zum Zitat Damin DC, Caetano MB, Rosito MA, Schwartsmann G, Damin AS, Frazzon AP et al (2007) Evidence for an association of human papillomavirus infection and colorectal cancer. Eur J Surg Oncol 33(5):569–574CrossRefPubMed Damin DC, Caetano MB, Rosito MA, Schwartsmann G, Damin AS, Frazzon AP et al (2007) Evidence for an association of human papillomavirus infection and colorectal cancer. Eur J Surg Oncol 33(5):569–574CrossRefPubMed
32.
Zurück zum Zitat Shah KV, Daniel RW, Simons JW, Vogelstein B (1992) Investigation of colon cancers for human papillomavirus genomic sequences by polymerase chain reaction. J Surg Oncol 51(1):5–7CrossRefPubMed Shah KV, Daniel RW, Simons JW, Vogelstein B (1992) Investigation of colon cancers for human papillomavirus genomic sequences by polymerase chain reaction. J Surg Oncol 51(1):5–7CrossRefPubMed
33.
Zurück zum Zitat Shroyer KR, Kim JG, Manos MM, Greer CE, Pearlman NW, Franklin WA (1992) Papillomavirus found in anorectal squamous carcinoma, not in colon adenocarcinoma. Arch Surg 127(6):741–744PubMed Shroyer KR, Kim JG, Manos MM, Greer CE, Pearlman NW, Franklin WA (1992) Papillomavirus found in anorectal squamous carcinoma, not in colon adenocarcinoma. Arch Surg 127(6):741–744PubMed
34.
Zurück zum Zitat de Roda Husman AM, Walboomers JM, van den Brule AJ, Meijer CJ, Snijders PJ (1995) The use of general primers GP5 and GP6 elongated at their 3′ ends with adjacent highly conserved sequences improves human papillomavirus detection by PCR. J Gen Virol 76(Pt 4):1057–1062CrossRefPubMed de Roda Husman AM, Walboomers JM, van den Brule AJ, Meijer CJ, Snijders PJ (1995) The use of general primers GP5 and GP6 elongated at their 3′ ends with adjacent highly conserved sequences improves human papillomavirus detection by PCR. J Gen Virol 76(Pt 4):1057–1062CrossRefPubMed
35.
Zurück zum Zitat Kleter B, van Doorn LJ, ter Schegget J, Schrauwen L, van Krimpen K, Burger M et al (1998) Novel short-fragment PCR assay for highly sensitive broad-spectrum detection of anogenital human papillomaviruses. Am J Pathol 153(6):1731–1739PubMed Kleter B, van Doorn LJ, ter Schegget J, Schrauwen L, van Krimpen K, Burger M et al (1998) Novel short-fragment PCR assay for highly sensitive broad-spectrum detection of anogenital human papillomaviruses. Am J Pathol 153(6):1731–1739PubMed
36.
Zurück zum Zitat van den Brule AJ, Pol R, Fransen-Daalmeijer N, Schouls LM, Meijer CJ, Snijders PJ (2002) GP5+/6+ PCR followed by reverse line blot analysis enables rapid and high-throughput identification of human papillomavirus genotypes. J Clin Microbiol 40(3):779–787CrossRefPubMed van den Brule AJ, Pol R, Fransen-Daalmeijer N, Schouls LM, Meijer CJ, Snijders PJ (2002) GP5+/6+ PCR followed by reverse line blot analysis enables rapid and high-throughput identification of human papillomavirus genotypes. J Clin Microbiol 40(3):779–787CrossRefPubMed
37.
Zurück zum Zitat Kleter B, van Doorn LJ, Schrauwen L, Molijn A, Sastrowijoto S, ter Schegget J et al (1999) Development and clinical evaluation of a highly sensitive PCR-reverse hybridization line probe assay for detection and identification of anogenital human papillomavirus. J Clin Microbiol 37(8):2508–2517PubMed Kleter B, van Doorn LJ, Schrauwen L, Molijn A, Sastrowijoto S, ter Schegget J et al (1999) Development and clinical evaluation of a highly sensitive PCR-reverse hybridization line probe assay for detection and identification of anogenital human papillomavirus. J Clin Microbiol 37(8):2508–2517PubMed
38.
Zurück zum Zitat Poynter JN, Gruber SB, Higgins PD, Almog R, Bonner JD, Rennert HS et al (2005) Statins and the risk of colorectal cancer. N Engl J Med 352(21):2184–2192CrossRefPubMed Poynter JN, Gruber SB, Higgins PD, Almog R, Bonner JD, Rennert HS et al (2005) Statins and the risk of colorectal cancer. N Engl J Med 352(21):2184–2192CrossRefPubMed
39.
Zurück zum Zitat Moreno V, Gemignani F, Landi S, Gioia-Patricola L, Chabrier A, Blanco I et al (2006) Polymorphisms in genes of nucleotide and base excision repair: risk and prognosis of colorectal cancer. Clin Cancer Res 12(7 Pt 1):2101–2108CrossRefPubMed Moreno V, Gemignani F, Landi S, Gioia-Patricola L, Chabrier A, Blanco I et al (2006) Polymorphisms in genes of nucleotide and base excision repair: risk and prognosis of colorectal cancer. Clin Cancer Res 12(7 Pt 1):2101–2108CrossRefPubMed
40.
Zurück zum Zitat Giordano TJ, Shedden KA, Schwartz DR, Kuick R, Taylor JM, Lee N et al (2001) Organ-specific molecular classification of primary lung, colon, and ovarian adenocarcinomas using gene expression profiles. Am J Pathol 159(4):1231–1238PubMed Giordano TJ, Shedden KA, Schwartz DR, Kuick R, Taylor JM, Lee N et al (2001) Organ-specific molecular classification of primary lung, colon, and ovarian adenocarcinomas using gene expression profiles. Am J Pathol 159(4):1231–1238PubMed
41.
Zurück zum Zitat Jacobs MV, Snijders PJ, van den Brule AJ, Helmerhorst TJ, Meijer CJ, Walboomers JM (1997) A general primer GP5+/GP6(+)-mediated PCR-enzyme immunoassay method for rapid detection of 14 high-risk and 6 low-risk human papillomavirus genotypes in cervical scrapings. J Clin Microbiol 35(3):791–795PubMed Jacobs MV, Snijders PJ, van den Brule AJ, Helmerhorst TJ, Meijer CJ, Walboomers JM (1997) A general primer GP5+/GP6(+)-mediated PCR-enzyme immunoassay method for rapid detection of 14 high-risk and 6 low-risk human papillomavirus genotypes in cervical scrapings. J Clin Microbiol 35(3):791–795PubMed
42.
Zurück zum Zitat DerSimonian R, Laird N (1986) Meta-analysis in clinical trials. Control Clin Trials 7(3):177–188CrossRefPubMed DerSimonian R, Laird N (1986) Meta-analysis in clinical trials. Control Clin Trials 7(3):177–188CrossRefPubMed
43.
Zurück zum Zitat Ades AE, Lu G, Higgins JP (2005) The interpretation of random-effects meta-analysis in decision models. Med Decis Making 25(6):646–654CrossRefPubMed Ades AE, Lu G, Higgins JP (2005) The interpretation of random-effects meta-analysis in decision models. Med Decis Making 25(6):646–654CrossRefPubMed
44.
Zurück zum Zitat Klug SJ, Molijn A, Schopp B, Holz B, Iftner A, Quint W et al (2008) Comparison of the performance of different HPV genotyping methods for detecting genital HPV types. J Med Virol 80(7):1264–1274CrossRefPubMed Klug SJ, Molijn A, Schopp B, Holz B, Iftner A, Quint W et al (2008) Comparison of the performance of different HPV genotyping methods for detecting genital HPV types. J Med Virol 80(7):1264–1274CrossRefPubMed
Metadaten
Titel
Human papillomavirus is not associated with colorectal cancer in a large international study
verfasst von
Michele C. Gornick
Xavier Castellsague
Gloria Sanchez
Thomas J. Giordano
Michelle Vinco
Joel K. Greenson
Gabriel Capella
Leon Raskin
Gad Rennert
Stephen B. Gruber
Victor Moreno
Publikationsdatum
01.05.2010
Verlag
Springer Netherlands
Erschienen in
Cancer Causes & Control / Ausgabe 5/2010
Print ISSN: 0957-5243
Elektronische ISSN: 1573-7225
DOI
https://doi.org/10.1007/s10552-010-9502-0

Weitere Artikel der Ausgabe 5/2010

Cancer Causes & Control 5/2010 Zur Ausgabe

Adjuvante Immuntherapie verlängert Leben bei RCC

25.04.2024 Nierenkarzinom Nachrichten

Nun gibt es auch Resultate zum Gesamtüberleben: Eine adjuvante Pembrolizumab-Therapie konnte in einer Phase-3-Studie das Leben von Menschen mit Nierenzellkarzinom deutlich verlängern. Die Sterberate war im Vergleich zu Placebo um 38% geringer.

Alectinib verbessert krankheitsfreies Überleben bei ALK-positivem NSCLC

25.04.2024 NSCLC Nachrichten

Das Risiko für Rezidiv oder Tod von Patienten und Patientinnen mit reseziertem ALK-positivem NSCLC ist unter einer adjuvanten Therapie mit dem Tyrosinkinase-Inhibitor Alectinib signifikant geringer als unter platinbasierter Chemotherapie.

Bei Senioren mit Prostatakarzinom auf Anämie achten!

24.04.2024 DGIM 2024 Nachrichten

Patienten, die zur Behandlung ihres Prostatakarzinoms eine Androgendeprivationstherapie erhalten, entwickeln nicht selten eine Anämie. Wer ältere Patienten internistisch mitbetreut, sollte auf diese Nebenwirkung achten.

ICI-Therapie in der Schwangerschaft wird gut toleriert

Müssen sich Schwangere einer Krebstherapie unterziehen, rufen Immuncheckpointinhibitoren offenbar nicht mehr unerwünschte Wirkungen hervor als andere Mittel gegen Krebs.

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.